Document is current
Any future updates will be listed below
-
Authors
Orozco-Jiménez, S. https://orcid.org/0000-0001-8426-8984
Rueda-Galvis, P. A. https://orcid.org/0000-0001-5976-2518
Builes-Montaño, C. E. https://orcid.org/0000-0002-2418-6159
Arango-Salgado, A. https://orcid.org/0000-0002-1523-4104
- License Information
-
More Information
Article History
Received: 2 November 2024
Revised: 21 December 2024
Accepted: 29 December 2024
First Online: 26 February 2025
Declarations
:
: The authors certify that they have no affiliation with or are involved with any organization or entity with any financial interest (such as fees, financial aid for education, shares, employment contracts, work as consultants, or any other type of interest) or non-financial interest (such as personal, professional relationships, affiliations, or beliefs) in the topic of interest or any material discussed in this manuscript. Carlos E. Builes-Montaño has received consulting or speaker fees from Sanofi, Novo Nordisk, Novartis, and Boehringer Ingelheim.
